Collectively, these results indicate that ZD55-SATB1 combined with DTX may inhibit prostate cancer growth by inducing apoptosis and inhibit prostate cancer invasion and metastasis by reversing EMT. This evidence concerns the gene SATB1 and prostate cancer.